Biotech Values

[DewDiligence]

[“Chevron”] is a horrid decision with very negative consequences for most of the country…

I think the decision is doubled-edged—sometimes it will work out well and sometimes it won’t. Let’s evaluate it after a few years have elapsed to ascertain whether the practical outcome is net negative or net positive.